We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$658M
AUM Growth
+$41.6M
Cap. Flow
-$2.26M
Cap. Flow %
-0.34%
Top 10 Hldgs %
27.12%
Holding
136
New
3
Increased
48
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.62M
2
YUM icon
Yum! Brands
YUM
+$1.59M
3
FDX icon
FedEx
FDX
+$1.53M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M
5
GLW icon
Corning
GLW
+$1.12M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.18M
2
CVX icon
Chevron
CVX
+$1.86M
3
META icon
Meta Platforms (Facebook)
META
+$1.69M
4
PXD
Pioneer Natural Resource Co.
PXD
+$1.02M
5
TELL
Tellurian Inc.
TELL
+$997K

Sector Composition

Rank Sector Weight
1 Technology 21.41%
2 Healthcare 18.95%
3 Industrials 13.46%
4 Communication Services 10.9%
5 Consumer Staples 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
101
Philip Morris
PM
$297B
$393K 0.06%
4,625
– –
BP icon
102
BP
BP
$116B
$370K 0.06%
9,815
– –
JPM icon
103
JPMorgan Chase
JPM
$935B
$341K 0.05%
2,452
+116
+5% +$14.9K
MO icon
104
Altria Group
MO
$114B
$309K 0.05%
6,210
– –
CVGW
105
DELISTED
Calavo Growers
CVGW
$308K 0.05%
3,403
– –
MPC icon
106
Marathon Petroleum
MPC
$92.4B
$305K 0.05%
5,065
– –
GE icon
107
GE Aerospace
GE
$374B
$289K 0.04%
5,201
-1,136
-18% -$58.7K
SCHB icon
108
Schwab US Broad Market ETF
SCHB
$43.2B
$284K 0.04%
22,194
-17,796
-45% -$218K
GAM
109
General American Investors Company
GAM
$1.56B
$283K 0.04%
7,516
– –
LMT icon
110
Lockheed Martin
LMT
$134B
$267K 0.04%
686
-62
-8% -$23.8K
EIX icon
111
Edison International
EIX
$28.2B
$262K 0.04%
3,475
– –
DD icon
112
DuPont de Nemours
DD
$18.5B
$260K 0.04%
3,232
-198
-6% -$16.4K
AEP icon
113
American Electric Power
AEP
$69.6B
$250K 0.04%
2,649
– –
SRE icon
114
Sempra
SRE
$57.9B
$249K 0.04%
3,300
-56
-2% -$4.11K
NFLX icon
115
Netflix
NFLX
$299B
$248K 0.04%
7,670
-300
-4% -$8.89K
TMO icon
116
Thermo Fisher Scientific
TMO
$213B
$239K 0.04%
737
-13
-2% -$3.94K
DOW icon
117
Dow Inc
DOW
$21.9B
$231K 0.04%
4,223
– –
HPE icon
118
Hewlett Packard
HPE
$63.4B
$217K 0.03%
13,688
+29
+0.2% +$463
RTX icon
119
RTX Corp
RTX
$290B
$211K 0.03%
+2,239
New +$203K
IOSP icon
120
Innospec
IOSP
$2.12B
$206K 0.03%
+2,000
New +$191K
MSI icon
121
Motorola Solutions
MSI
$72.3B
$206K 0.03%
1,284
– –
AMD icon
122
Advanced Micro Devices
AMD
$776B
– –
-17,000
Closed -$492K
CMCSA icon
123
Comcast
CMCSA
$85B
– –
-5,124
Closed -$230K
HBAN icon
124
Huntington Bancshares
HBAN
$34.4B
– –
-18,400
Closed -$262K
IQ icon
125
iQIYI
IQ
$1.23B
– –
-34,052
Closed -$549K
2 3 4
5
6

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs & Co held 136 positions worth $658M, up 6.8% from $617M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jacobs & Co's Q4 2019 filing shows 3 new, 48 increased, 56 reduced and 10 closed positions. Its largest new stake was Biogen: 9,440 shares worth $2.8M. The largest sale was Celgene Corp, an estimated $2.18M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2019 buy was Biogen: 9,440 shares worth $2.8M.
  • Jacobs & Co added most to Yum! Brands in Q4 2019, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q4 2019 reduction was Chevron, cutting an estimated $1.86M.
  • Jacobs & Co fully exited Celgene Corp in Q4 2019, selling an estimated $2.18M.
  • Jacobs & Co's ten largest holdings make up 27% of its $658M portfolio in Q4 2019.
  • Jacobs & Co opened 3 new positions and closed 10 in Q4 2019.
  • Jacobs & Co's portfolio value rose 6.8% quarter-over-quarter to $658M.

Based on Jacobs & Co's 13F filing for Q4 2019, filed 29 Jan 2020.